Feds Pass on Asking Full Appeals Court to Reconsider Adverse 340B Contract Pharmacy Ruling and Vacate Enforcement Letters to Three Manufacturers

Third Circuit Court
The federal government opted not to ask a federal appeals court to reconsider its opinion upholding three drug makers' restrictions on 340B pricing when their drugs are shipped to be dispensed by contract pharmacies.

The federal government yesterday decided not to ask all 14 judges on the U.S. Third Circuit Court of Appeals in Philadelphia to review a three-judge panel’s unanimous January opinion upholding AstraZeneca, Novo Nordisk, and Sanofi’s restrictions on 340B pricing when

Read More »

Calif. Contract Pharmacy Overbilled Medicaid for 340B Drugs, State Appeals Court Holds

PharmBlue specialty pharmacy wordmark
A California state appeals court affirmed a lower ruling that 340B contract pharmacy PharmBlue overbilled the state for 340B drugs it obtained from manufacturers on its clients' behalf.

A California state appeals court has affirmed a lower state court’s judgement that a 340B contract pharmacy overcharged the state Medicaid agency, Medi-Cal, nearly $2.5 million more than the pharmacy was entitled to receive for 340B drugs between May 2015

Read More »

Arkansas and 340B Providers Ask Appeals Court to Back State’s Novel 340B Contract Pharmacy Law

Arkansas Act 1103 text excerpt.
The state of Arkansas and Arkansas 340B covered entities asked a federal appeals court yesterday to uphold the state's novel 340B anti-discrimination law.

The state of Arkansas and Arkansas 340B covered entities separately asked a federal appeals court yesterday to back a judge’s decision in December that the state’s novel 340B anti-discrimination law is not preempted by the 340B statute nor by the

Read More »

Novartis to Appeals Court: Our New 340B Contract Pharmacy Policy Doesn’t Affect Our Case Before You

Novartis wordmark on a building
Novartis told a federal appeals court its revised 340B contract pharmacy policy doesn't affect its 340B contract pharmacy case awaiting the court’s decision.

Drug maker Novartis told a federal appeals court in Washington, D.C. Tuesday its revised 340B contract pharmacy policy “does not impact the legal arguments at issue” in its 340B contract pharmacy case awaiting the court’s decision.

If the court disagrees,

Read More »

340B Prime Vendor Apexus Asks Court to Dismiss AIDS Healthcare Foundation’s Breach of Contract Suit

USDC Central District of California building with Great Seal of the United States
The 340B prime vendor Apexus asked the federal district court in Los Angeles to dismiss AIDS Healthcare Foundation's claims that Apexus failed and refused to negotiate sub-ceiling discounts on HIV/AIDS drugs.

Apexus, the federally contracted 340B prime vendor, asked a federal district judge in Los Angeles on Friday to dismiss AIDS Healthcare Foundation’s lawsuit alleging that Apexus has failed and refused to negotiate sub-ceiling 340B discounts on HIV/AIDS prescription drugs pursuant

Read More »

N.Y. State Judge Dismisses 340B-Related Antitrust Suit Against CVS

CVS Health signage
A New York State judge dismissed the state attorney general's 340B-related antitrust lawsuit against CVS Health.

A New York State judge has dismissed the state’s antitrust lawsuit alleging that CVS Health illegally makes 340B covered entities use its 340B third party administrator Wellpartner in order to contract with CVS retail and specialty pharmacies to dispense 340B-purchased

Read More »

Feds Considering Asking Full Appeals Court to Rehear Case Over AstraZeneca, Novo Nordisk, and Sanofi’s 340B Contract Pharmacy Policies

Seal of the U.S. Court of Appeals for the Third Circuit
HHS might ask the full U.S. Third Circuit Court of Appeals to rehear a a lawsuit over AstraZeneca, Novo Nordisk, and Sanofi’s 340B contract pharmacy policies.

The federal government may ask all 14 judges on the U.S. Third Circuit Court of Appeals to review a three-judge panel’s unanimous January opinion upholding AstraZeneca, Novo Nordisk, and Sanofi’s restrictions on 340B pricing when their drugs are shipped to

Read More »

Arkansas 340B Contract Pharmacy Law “Trespassed on Exclusively Federal Turf,” PhRMA Tells Appeals Court

US Eighth Circuit Court of Appeals building
Arkansas's 340B contract pharmacy law "impermissibly trespassed on exclusively federal turf,” PhRMA told a federal appeals court in St. Louis.

Pharmaceutical Research and Manufacturers of America asked a U.S. appeals court in St. Louis, Mo. last week to strike down Arkansas’s first-of-its-kind 340B contract pharmacy law, arguing that it intrudes on the 340B statute and frustrates Congress’ intent to limit

Read More »

Judge Pauses PhRMA’s 340B Administrative Dispute Resolution Lawsuit

US District courthouse and signage in Baltimore, MD
A federal district judge in Baltimore has paused PhRMA's lawsuit challenging the current 340B program administrative dispute resolution process.

A federal district judge in Baltimore, Md., yesterday stayed the brand drug industry’s lawsuit challenging the December 2020 340B program administrative dispute resolution final rule.

Lawyers for Pharmaceutical Research and Manufacturers of America and U.S. Health and Human Services Secretary

Read More »

Calif. Medicaid Drug Benefit Transfer Will Harm Care at 340B Health Centers, National and State Groups Tell Court

US District Court Sacramento building and United States flag
The National Association of Community Health Centers and the California Primary Care Association filed briefs in federal district court in Sacramento in a case that seeks to reverse California’s shift of Medicaid pharmacy benefits to Medicaid fee for service.

National and state health center associations have filed amicus briefs in a lawsuit over California’s shift of Medicaid pharmacy benefits to Medicaid fee for service. They say the move will cost 340B providers in the state millions in savings needed

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer